This report was sent to Briefing.com subscribers earlier today. https:\/\/briefing.com<\/p>\n
> <\/strong>Acadia Healthcare (ACHC) upgraded to Buy from Hold at Loop Capital; tgt raised to $95<\/p>\n > <\/strong>Becton Dickinson (BDX) upgraded to Neutral from Sell at Citigroup; tgt raised to $250<\/p>\n > <\/strong>Best Buy (BBY) upgraded to Neutral from Sell at Goldman; tgt raised to $83<\/p>\n > <\/strong>Bio-Techne (TECH) upgraded to Buy from Neutral at Citigroup; tgt raised to $100<\/p>\n > <\/strong>Box (BOX) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $34<\/p>\n > <\/strong>CAE (CAE) upgraded to Overweight from Equal-Weight at Morgan Stanley<\/p>\n > <\/strong>Cielo SA (CIOXY) upgraded to Buy from Neutral at UBS<\/p>\n > <\/strong>Colliers (CIGI) upgraded to Buy from Neutral at Goldman<\/p>\n > <\/strong>Coupa Software (COUP) upgraded to Outperform from Neutral at SMBC Nikko<\/p>\n > <\/strong>Crane (CR) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $129<\/p>\n > <\/strong>Gap (GPS) upgraded to Buy from Neutral at Goldman; tgt $18<\/p>\n > <\/strong>Glaukos (GKOS) upgraded to Buy from Neutral at Citigroup; tgt $57<\/p>\n > <\/strong>John Wood Group plc (WDGJF) upgraded to Buy from Hold at Jefferies<\/p>\n > <\/strong>Lam Research (LRCX) upgraded to Buy from Hold at Deutsche Bank; tgt raised to $520<\/p>\n > <\/strong>Monday.com (MNDY) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $140<\/p>\n > <\/strong>Montrose Environmental Group (MEG) upgraded to Buy from Neutral at BofA Securities<\/p>\n > <\/strong>PerkinElmer (PKI) upgraded to Buy from Neutral at Citigroup; tgt raised to $170<\/p>\n > <\/strong>Pulmonx (LUNG) upgraded to Buy from Neutral at Citigroup; tgt lowered to $10<\/p>\n > <\/strong>QuidelOrtho (QDEL) upgraded to Buy from Neutral at Citigroup; tgt raised to $125<\/p>\n > <\/strong>Southern (SO) upgraded to Outperform from Peer Perform at Wolfe Research; tgt $76<\/p>\n > <\/strong>Tapestry (TPR) upgraded to Buy from Neutral at Goldman; tgt raised to $44<\/p>\n > <\/strong>Teledyne Tech (TDY) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt raised to $488<\/p>\n > <\/strong>Under Armour (UAA) upgraded to Buy from Hold at Stifel; tgt raised to $12<\/p>\n > <\/strong>Accenture (ACN) downgraded to Underweight from Neutral at Piper Sandler; tgt $268<\/p>\n > <\/strong>Allogene (ALLO) downgraded to Underperform from Buy at BofA Securities; tgt lowered to $9<\/p>\n > <\/strong>Baxter (BAX) downgraded to Neutral from Buy at Citigroup; tgt lowered to $58<\/p>\n > <\/strong>Boyd Gaming (BYD) downgraded to Mkt Perform from Mkt Outperform at JMP Securities<\/p>\n > <\/strong>Brinker (EAT) downgraded to Sell from Neutral at Goldman; tgt lowered to $28<\/p>\n > <\/strong>Cap Gemini S.A. (CGEMY) downgraded to Equal-Weight from Overweight at Morgan Stanley<\/p>\n > <\/strong>Cheesecake Factory (CAKE) downgraded to Sell from Neutral at Goldman; tgt lowered to $29<\/p>\n > <\/strong>Coterra Energy (CTRA) downgraded to Hold from Buy at Truist; tgt $26<\/p>\n > <\/strong>Curtiss-Wright (CW) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt raised to $188<\/p>\n > <\/strong>Deutsche Boerse (DBOEY) downgraded to Neutral from Overweight at JP Morgan<\/p>\n > <\/strong>DraftKings (DKNG) downgraded to Neutral from Buy at ROTH Capital; tgt $15<\/p>\n > <\/strong>Genuine Parts (GPC) downgraded to Sell from Neutral at Goldman; tgt raised to $147<\/p>\n > <\/strong>HEICO (HEI) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $172<\/p>\n > <\/strong>Illumina (ILMN) downgraded to Sell from Neutral at Citigroup; tgt lowered to $180<\/p>\n > <\/strong>Johnson Controls (JCI) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $72<\/p>\n > <\/strong>KLA Corporation (KLAC) downgraded to Hold from Buy at Deutsche Bank; tgt raised to $400<\/p>\n > <\/strong>L’Oreal (LRLCY) downgraded to Underperform from Sector Perform at RBC Capital Mkts<\/p>\n > <\/strong>Laboratory Corp (LH) downgraded to Neutral from Buy at Citigroup; tgt lowered to $250<\/p>\n > <\/strong>Leggett & Platt (LEG) downgraded to Underweight from Neutral at Piper Sandler; tgt lowered to $24<\/p>\n > <\/strong>Levi Strauss (LEVI) downgraded to Neutral from Buy at Goldman; tgt $17<\/p>\n > <\/strong>Micron (MU) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $55<\/p>\n > <\/strong>Moog (MOG.A) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt raised to $89<\/p>\n > <\/strong>Murphy Oil (MUR) downgraded to Hold from Buy at Truist; tgt $46<\/p>\n > <\/strong>Nevro (NVRO) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $43<\/p>\n > <\/strong>Newmark Group (NMRK) downgraded to Sell from Neutral at Goldman; tgt $8<\/p>\n > <\/strong>OceanFirst Finl (OCFC) downgraded to Neutral from Overweight at Piper Sandler; tgt $25<\/p>\n > <\/strong>PDC Energy (PDCE) downgraded to Hold from Buy at Truist; tgt $68<\/p>\n > <\/strong>Qualcomm (QCOM) downgraded to Underweight from Equal Weight at Wells Fargo; tgt $105<\/p>\n > <\/strong>RH (RH) downgraded to Sell from Neutral at Goldman; tgt lowered to $215<\/p>\n > <\/strong>Rockwell Automation (ROK) downgraded to Neutral from Buy at BofA Securities<\/p>\n > <\/strong>RxSight (RXST) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $14<\/p>\n > <\/strong>ShockWave Medical (SWAV) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $235<\/p>\n > <\/strong>Spire (SR) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $61<\/p>\n > <\/strong>Trane (TT) downgraded to Underperform from Neutral at BofA Securities; tgt $160<\/p>\n > <\/strong>Ulta Beauty (ULTA) downgraded to Neutral from Buy at Goldman; tgt lowered to $508<\/p>\n > <\/strong>Vontier (VNT) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $21<\/p>\n > <\/strong>Acrivon Therapeutics (ACRV) initiated with a Buy at Jefferies; tgt $17<\/p>\n > <\/strong>Acrivon Therapeutics (ACRV) initiated with an Outperform at Cowen<\/p>\n > <\/strong>Acrivon Therapeutics (ACRV) initiated with an Overweight at Piper Sandler; tgt $25<\/p>\n > <\/strong>Affimed Therapeutics (AFMD) initiated with a Buy at H.C. Wainwright; tgt $6<\/p>\n > <\/strong>Ageas SA\/NV (AGESY) initiated with a Sell at Goldman<\/p>\n > <\/strong>Alcon (ALC) assumed with a Buy at Citigroup<\/p>\n > <\/strong>Ambarella (AMBA) initiated with a Positive at Susquehanna; tgt $90<\/p>\n > <\/strong>Analog Devices (ADI) initiated with a Positive at Susquehanna; tgt $205<\/p>\n > <\/strong>Coinbase Global (COIN) initiated with a Sector Weight at KeyBanc Capital Markets<\/p>\n > <\/strong>Elekta AB (EKTAY) initiated with a Sell at Citigroup<\/p>\n > <\/strong>Essilor International (ESLOY) initiated with a Buy at Citigroup<\/p>\n > <\/strong>Fresenius SE (FSNUY) initiated with a Buy at Citigroup<\/p>\n > <\/strong>GN Store Nord (GGNDF) initiated with a Buy at Citigroup<\/p>\n > <\/strong>Kinsale Capital (KNSL) initiated with a Hold at Jefferies; tgt $295<\/p>\n > <\/strong>Mativ Holdings (MATV) initiated with a Market Outperform at CJS Securities; tgt $32<\/p>\n > <\/strong>NN Group (NNGPF) initiated with a Buy at Goldman<\/p>\n > <\/strong>Palomar Holdings (PLMR) initiated with a Hold at Jefferies; tgt $55<\/p>\n > <\/strong>Royal Gold (RGLD) assumed with a Neutral at Credit Suisse; tgt $120<\/p>\n > <\/strong>Smith & Nephew (SNN) initiated with a Buy at Citigroup<\/p>\n > <\/strong>Sonova (SONVY) initiated with a Sell at Citigroup<\/p>\nDowngrades:<\/h2>\n
Others:<\/h2>\n